This site is intended for health professionals only

Views

Takeda presents new data in management of type 2 diabetes
Takeda presents new data in management of type 2 diabetes
BD to support implementation of new ‘Sharps Instruments in Healthcare Regulations’
BD to support implementation of new ‘Sharps Instruments in Healthcare Regulations’
Managing pain in renal impairment
Managing pain in renal impairment
European Commission approves new twice daily dosing of INCIVO®
European Commission approves new twice daily dosing of INCIVO®
NICE publishes positive Final Appraisal Determination for dapagliflozin
NICE publishes positive Final Appraisal Determination for dapagliflozin
Topical anaesthetics in dermatology
Topical anaesthetics in dermatology
By Rod Tucker
Treating severe debilitating tophaceous gout
Treating severe debilitating tophaceous gout
Type 2 diabetes educational game
Type 2 diabetes educational game
Elderly type 2 diabetes
Elderly type 2 diabetes
Positive late-stage results for fasiglifam
Positive late-stage results for fasiglifam
Boehringer Ingelheim responds to FDA warning letter
Boehringer Ingelheim responds to FDA warning letter
Phase III trial of regorafenib in patients with advanced liver cancer
Phase III trial of regorafenib in patients with advanced liver cancer
1 … 17 18 19 20 21 … 39





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x